<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02017756</url>
  </required_header>
  <id_info>
    <org_study_id>Tsinghua-985</org_study_id>
    <nct_id>NCT02017756</nct_id>
  </id_info>
  <brief_title>Chinese Atherosclerosis Risk Evaluation- Phase II</brief_title>
  <acronym>CARE-II</acronym>
  <official_title>A Phase II Study of Chinese Atherosclerosis Risk Evaluation: Investigation of Carotid Atherosclerotic Disease in Patients With Ischemic Cerebrovascular Events</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tsinghua University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tsinghua University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Stroke is the first and the fourth leading cause of death in the United States and China,
      respectively. Disruption of cerebrovascular vulnerable atherosclerotic plaque is the major
      etiology of ischemic stroke. Therefore, early detection and treatment of vulnerable plaques
      occurring at the feeding arteries to brain (cerebral arteries) will be helpful for prevention
      of stroke.

      Atherosclerosis is a systemic disease that usually affects multiple vascular beds. Previous
      studies have shown that these high risk lesions in different segments of cerebral arteries
      (intracranial and extracranial arteries) might be racially specific. It is reported that, in
      stroke patients, intracranial vulnerable plaques are prevalent in Asian populations whereas
      atherosclerosis more frequently involves extracranial carotid arteries in American subjects.
      However, these findings are based on angiographic imaging approaches via measuring arterial
      luminal stenosis. Because the atherosclerotic plaque often appears as outward expansion,
      namely positive remodeling during progression, measuring luminal stenosis will underestimate
      the disease severity. Hence, directly viewing the plaque in the vessel wall is strongly
      suggested in order to objectively evaluate the cerebrovascular vulnerable plaque.

      High resolution, black-blood magnetic resonance (MR) imaging has been widely used to
      accurately characterize carotid vulnerable plaque in the last two decades. The aim of using
      MR black-blood techniques is to suppress the blood signal (black) to enhance the signal
      contrast between the vessel wall and blood in the arterial lumen. Excellent agreement has
      been achieved between MR imaging and histology in identification of plaque components, such
      as intraplaque hemorrhage and lipid core. For assessing carotid plaque, MR imaging is
      superior to computed tomography and ultrasound imaging techniques due to its advantages
      including noninvasive imaging, lack of ionizing radiation, excellent soft tissue resolution,
      and multi-parametric image acquisition.

      The Investigators hypothesize that there are specific characteristics in carotid vulnerable
      plaques in Chinese patients with ischemic cerebrovascular events such as ischemic stroke and
      transient ischemic attack (TIA). This study seeks to investigate the characteristics of
      vulnerable plaque in carotid arteries using high resolution, black-blood MR imaging in
      patients with recent TIA or ischemic stroke.

      This is a cross-sectional, multicenter study. A total of 1000 patients will be recruited from
      more than 10 different hospitals across China within 3 years. All patients will undergo MR
      imaging for brain and carotid arteries within two weeks after symptom onset. The prevalence
      of carotid vulnerable plaque and its correlations with brain ischemic lesions, traditional
      risk factors, and regional distribution of China will be determined.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2012</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">June 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Prevalence of carotid vulnerable plaques, defined as lesions with intraplaque hemorrhage, fibrous cap rupture, or lipid core occupying &gt;40% of vessel wall area as determined by high resolution, black-blood MR imaging in this study population.</measure>
    <time_frame>within two weeks after symptom onset</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Carotid wall and brain infarct measurements.</measure>
    <time_frame>within two weeks after symptom onset</time_frame>
    <description>The following features will be measured: carotid mean wall thickness, normalized wall index, and incidence of compositional features (calcification, lipid core, intraplaque hemorrhage, cap rupture) and volume of cerebral white matter lesions or infarcts.
These measurements will be used to determine the relationship of carotid wall features with the volume of cerebral white matter lesions or infarcts.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Traditional risk factors.</measure>
    <time_frame>within two weeks after symptom onset</time_frame>
    <description>Traditional risk factors will be collected from subjects including: age, gender, hypertension, smoke, diabetes, and history of cardiovascular disease. The association of the volume and incidence of carotid plaque calcification, lipid core, and intraplaque hemorrhage with traditional risk factors will be evaluated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence and volume of carotid plaques and geographic region of subjects.</measure>
    <time_frame>within two weeks after symptom onset</time_frame>
    <description>The incidence and the volume of carotid plaque calcification, lipid core, and intraplaque hemorrhage will be measured and collected. Data on geographic region of subjects in China, such as Northeast, North, East, South, and Western areas will be collected. This data will be used to study compare incidence and volume of carotid plaque features with geographic regions of subjects.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Ischemic Stroke</condition>
  <condition>Transient Ischemic Attack</condition>
  <condition>Carotid Atherosclerotic Disease</condition>
  <eligibility>
    <study_pop>
      <textblock>
        In this study, we plan to recruit patients with recent TIA of ischemic stroke (within 2
        weeks) and carotid atherosclerotic plaque determined by ultrasound. The patients will be
        recruited from more than 10 hospitals in different areas of China.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with recent TIA of ischemic stroke (2 weeks) and carotid plaque determined by
             ultrasound will be included in this study.

        Exclusion Criteria:

          -  Patients with contraindications to MR scan

          -  Patients with hemorrhagic stroke

          -  Patients with evidence of cardiogenic stroke

          -  Patients with brain tumors

          -  Patients underwent carotid revascularization therapy, such as stenting and
             endarterectomy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chun Yuan, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Center for Biomedical Imaging Research, Department of Biomedical Engineering, Tsinghua University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xihai Zhao, MD, PhD</last_name>
    <phone>861062792662</phone>
    <email>xihaizhao@tsinghua.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Rui Li, PhD</last_name>
    <phone>861062785758</phone>
    <email>leerui@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Radiology, Peking University First Hospital</name>
      <address>
        <city>Beijing</city>
        <zip>100034</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Feiyu Li, MD, PhD</last_name>
      <phone>8613552292893</phone>
      <email>redwindowlfy@163.com</email>
    </contact>
    <investigator>
      <last_name>Xiaoying Wang, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Center for Biomedical Imaging Research, Department of Biomedical Engineering, Tsinghua University</name>
      <address>
        <city>Beijing</city>
        <zip>100084</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Le He, MD</last_name>
      <phone>861062796175</phone>
      <email>hele0806@aliyun.com</email>
    </contact>
    <investigator>
      <last_name>Xihai Zhao, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Radiology, Beijing Hospital</name>
      <address>
        <city>Beijing</city>
        <zip>100730</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yan Song, MD, PhD</last_name>
      <phone>8618610566272</phone>
      <email>songyan@u.washington.edu</email>
    </contact>
    <investigator>
      <last_name>Min Chen, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Radiology, PLA General Hospital</name>
      <address>
        <city>Beijing</city>
        <zip>100853</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xu Han, MD</last_name>
      <phone>8613810139203</phone>
      <email>hxlryt@126.com</email>
    </contact>
    <investigator>
      <last_name>Jianming Cai, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Radiology, Fujian Medical University Union Hospital</name>
      <address>
        <city>Fuzhou</city>
        <zip>350001</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yunjing Xue, MD, PhD</last_name>
      <phone>8613950497808</phone>
      <email>xueyunjing@126.com</email>
    </contact>
    <investigator>
      <last_name>Qing Duan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Radiology, Sun Yat-Sen Memorial Hospital</name>
      <address>
        <city>Guangzhou</city>
        <zip>510120</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mingwei Xie, MD</last_name>
      <phone>15018722452</phone>
      <email>553614809@qq.com</email>
    </contact>
    <investigator>
      <last_name>Biling Liang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Radiology, Zhujiang Hospital of Southern Medical University</name>
      <address>
        <city>Guangzhou</city>
        <zip>510282</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jing Zhang, MD</last_name>
      <phone>8615521118683</phone>
      <email>zzjing881205@163.com</email>
    </contact>
    <investigator>
      <last_name>Zhibo Wen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Radiology, Harbin University The Fourth Affiliated Hospital</name>
      <address>
        <city>Harbin</city>
        <zip>150001</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yang Ji, MD</last_name>
      <phone>8613654557419</phone>
      <email>jiyang19871104@126.com</email>
    </contact>
    <investigator>
      <last_name>Dan Wang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shandong Medical Imaging Research Institute</name>
      <address>
        <city>Jinan</city>
        <zip>250021</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Honglu Shi, MD</last_name>
      <phone>15053177828</phone>
      <email>shlkb08@163.com</email>
    </contact>
    <investigator>
      <last_name>Guangbin Wang, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Radiology, Nanjing Drum Tower Hospital</name>
      <address>
        <city>Nanjing</city>
        <zip>210008</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maoxue Wang, MD</last_name>
      <phone>8615851803070</phone>
      <email>fmriwangmx@126.com</email>
    </contact>
    <investigator>
      <last_name>Bing Zhang, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Radiology, The First Hospital of Qiqihaer City</name>
      <address>
        <city>Qiqihar</city>
        <zip>161005</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhong Zhuang, MD</last_name>
      <phone>8618245281102</phone>
      <email>zz_15880732@126.com</email>
    </contact>
    <investigator>
      <last_name>Xiaogang Peng, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Radiology, Shanghai Renji Hospital</name>
      <address>
        <city>Shanghai</city>
        <zip>200127</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Huilin Zhao, MD</last_name>
      <phone>8613918666437</phone>
      <email>huilinzhao2013@163.com</email>
    </contact>
    <investigator>
      <last_name>Jianrong Xu, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Radiology, Tianjin Fourth Centre Hospital</name>
      <address>
        <city>Tianjin</city>
        <zip>300140</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiao Gao, MD</last_name>
      <phone>13920924729</phone>
      <email>03092901010@163.com</email>
    </contact>
    <investigator>
      <last_name>Shengzhang Ji, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Radiology, Qinghai University Affiliated Hospital</name>
      <address>
        <city>Xining</city>
        <zip>810001</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuntai Cao, MD</last_name>
      <phone>8615003666895</phone>
      <email>caoyuntai04@126.com</email>
    </contact>
    <investigator>
      <last_name>Haihua Bao, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Liu L, Wang D, Wong KS, Wang Y. Stroke and stroke care in China: huge burden, significant workload, and a national priority. Stroke. 2011 Dec;42(12):3651-4. doi: 10.1161/STROKEAHA.111.635755. Epub 2011 Nov 3. Review.</citation>
    <PMID>22052510</PMID>
  </reference>
  <reference>
    <citation>Wong KS, Li H, Chan YL, Ahuja A, Lam WW, Wong A, Kay R. Use of transcranial Doppler ultrasound to predict outcome in patients with intracranial large-artery occlusive disease. Stroke. 2000 Nov;31(11):2641-7.</citation>
    <PMID>11062288</PMID>
  </reference>
  <reference>
    <citation>Saam T, Underhill HR, Chu B, Takaya N, Cai J, Polissar NL, Yuan C, Hatsukami TS. Prevalence of American Heart Association type VI carotid atherosclerotic lesions identified by magnetic resonance imaging for different levels of stenosis as measured by duplex ultrasound. J Am Coll Cardiol. 2008 Mar 11;51(10):1014-21. doi: 10.1016/j.jacc.2007.10.054.</citation>
    <PMID>18325441</PMID>
  </reference>
  <reference>
    <citation>Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med. 1987 May 28;316(22):1371-5.</citation>
    <PMID>3574413</PMID>
  </reference>
  <reference>
    <citation>Cai JM, Hatsukami TS, Ferguson MS, Small R, Polissar NL, Yuan C. Classification of human carotid atherosclerotic lesions with in vivo multicontrast magnetic resonance imaging. Circulation. 2002 Sep 10;106(11):1368-73.</citation>
    <PMID>12221054</PMID>
  </reference>
  <reference>
    <citation>Yuan C, Mitsumori LM, Ferguson MS, Polissar NL, Echelard D, Ortiz G, Small R, Davies JW, Kerwin WS, Hatsukami TS. In vivo accuracy of multispectral magnetic resonance imaging for identifying lipid-rich necrotic cores and intraplaque hemorrhage in advanced human carotid plaques. Circulation. 2001 Oct 23;104(17):2051-6.</citation>
    <PMID>11673345</PMID>
  </reference>
  <reference>
    <citation>Saam T, Cai JM, Cai YQ, An NY, Kampschulte A, Xu D, Kerwin WS, Takaya N, Polissar NL, Hatsukami TS, Yuan C. Carotid plaque composition differs between ethno-racial groups: an MRI pilot study comparing mainland Chinese and American Caucasian patients. Arterioscler Thromb Vasc Biol. 2005 Mar;25(3):611-6. Epub 2005 Jan 13.</citation>
    <PMID>15653565</PMID>
  </reference>
  <verification_date>December 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 4, 2013</study_first_submitted>
  <study_first_submitted_qc>December 16, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 23, 2013</study_first_posted>
  <last_update_submitted>December 16, 2013</last_update_submitted>
  <last_update_submitted_qc>December 16, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 23, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tsinghua University</investigator_affiliation>
    <investigator_full_name>Chun Yuan</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Carotid artery</keyword>
  <keyword>Atherosclerosis</keyword>
  <keyword>Vulnerable plaque</keyword>
  <keyword>Magnetic resonance imaging</keyword>
  <keyword>Arterial wall</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Atherosclerosis</mesh_term>
    <mesh_term>Ischemic Attack, Transient</mesh_term>
    <mesh_term>Carotid Artery Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

